SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Fan ST, Lo CM, Liu CL, Lam CM, Yuen WK, Yeung C, et al. Hepatectomy for hepatocellular carcinoma: towards zero hospital deaths. Ann Surg 1999; 229: 32230.
  • 2
    Harada T, Shigemura T, Kodama S, Higuchi T, Ikeda S, Okazaki M. Hepatic resection is not enough for hepatocellular carcinoma. A follow-up study of 92 patients. J Clin Gastroenterol 1992; 14: 24550.
  • 3
    Nagasue N, Uchida M, Makino Y, Takemoto Y, Yamanoi A, Hayashi T, et al. Incidence and factors associated with intrahepatic recurrence following resection of hepatocellular carcinoma. Gastroenterology 1993; 105: 48894.
  • 4
    Jwo SC, Chiu JH, Chau GY, Loong CC, Lui WY. Risk factors linked to tumor recurrence of human hepatocellular carcinoma after hepatic resection. Hepatology 1992; 16: 136771.
  • 5
    Yamamoto J, Kosuge T, Takayama T, Shimada K, Yamasaki S, Ozaki H, et al. Recurrence of hepatocellular carcinoma after surgery. Br J Surg 1998; 83: 121922.
  • 6
    Nagao T, Inoue S, Yoshimi F, Sodeyama M, Omori Y, Mizuta T, et al. Postoperative recurrence of hepatocellular carcinoma. Ann Surg 1990; 211: 2833.
  • 7
    Vauthey JN, Klimstra D, Franceschi D, Tao Y, Fortner J, Blumgart L, et al. Factors affecting long-term outcome after hepatic resection for hepatocellular carcinoma. Am J Surg 1995; 169: 2835.
  • 8
    Shimada M, Takenaka K, Taguchi K, Fujiwara Y, Gion T, Kajiyama K, et al. Prognostic factors after repeat hepatectomy for recurrent hepatocellular carcinoma. Ann Surg 1998; 227: 805.
  • 9
    Ko S, Nakajima Y, Kanehiro H, Hisanaga M, Aomatsu Y, Kin T, et al. Significant influence of accompanying chronic hepatitis status on recurrence of hepatocellular carcinoma after hepatectomy. Results of multivariate analysis. Ann Surg 1996;224: 5915.
  • 10
    Sasaki Y, Imaoka S, Masutani S, Ohashi I, Ishikawa O, Koyama H, et al. Influence of coexisting cirrhosis on long-term prognosis after surgery in patients with hepatocellular carcinoma. Surgery 1992; 112: 51521.
  • 11
    Shimada M, Takenaka K, Gion T, Fujiwara Y, Kajiyama K, Maeda T, et al. Prognosis of recurrent hepatocellular carcinoma: a 10-year surgical experience in Japan. Gastroenterology 1996; 111: 7206.
  • 12
    Poon RTP, Fan ST, Lo CM, Liu CL, Wong J. Intrahepatic recurrence after curative resection for hepatocellular carcinoma: long-term results of treatment and prognostic factors. Ann Surg 1999; 229: 21622.
  • 13
    Matsumata T, Kanematsu T, Takenaka K, Yoshida Y, Nishizaki T, Sugimachi K. Patterns of intrahepatic recurrence after curative resection of hepatocellular carcinoma. Hepatology 1989; 9: 45760.
  • 14
    SobinLH, WittekindCh, editors. TNM classification of malignant tumours. 5th ed. New York: John Wiley, 1997.
  • 15
    Lai ECS, Lo CM, Fan ST, Liu CL, Wong J. Postoperative adjuvant chemotherapy after curative resection of hepatocellular carcinoma: a randomized controlled trial. Arch Surg 1998; 133: 1838.
  • 16
    Kumada T, Nakano S, Takeda I, Sugiyama K, Osada T, Kiriyama S, et al. Patterns of recurrence after initial treatment in patients with small hepatocellular carcinoma. Hepatology 1997; 25: 8792.
  • 17
    Takenaka K, Adachi E, Nishizaki T, Hiroshige K, Ikeda T, Tsuneyoshi M, et al. Possible multicentric occurrence of hepatocellular carcinoma: a clinicopathological study. Hepatology 1994; 19: 88994.
  • 18
    Yamanaka N, Okamoto E, Fujihara S, Kato T, Fujimoto J, Oriyama T, et al. Do the tumor cells of hepatocellular carcinomas dislodge into the portal venous stream during hepatic resection? Cancer 1992; 70: 22637.
  • 19
    Sonoda T, Kanematsu T, Takenaka K, Sugimachi K. Ruptured hepatocellular carcinoma evokes risk of implanted metastases. J Surg Oncol 1989; 41: 1836.
  • 20
    Yamagata M, Maeda T, Shirabe K, Nishizaki T, Koyanagi N. Surgical results of spontaneously ruptured hepatocellular carcinoma. Hepatogastroenterology 1995; 42: 4614.
  • 21
    Ong GB, Chu EPH, Yu FYK, Lee TC. Spontaneous rupture of hepatocellular carcinoma. Br J Surg 1965; 52: 1239.
  • 22
    Zhu LX, Wang GS, Fan ST. Spontaneous rupture of hepatocellular carcinoma. Br J Surg 1996; 83: 6027.
  • 23
    Nagasue N, Inokuchi K, Obayashi M, Saku M. Hepatoportal arteriovenous fistula in primary carcinoma of the liver. Surg Gynecol Obstet 1977; 145: 5048.
  • 24
    Tarao K, Ohkawa S, Shimizu A, Harada M, Nakamura Y, Ito Y, et al. Significance of hepatocellular proliferation in the development of hepatocellular carcinoma from anti-hepatitis C virus-positive cirrhotic patients. Cancer 1994; 73: 114954.
  • 25
    Rua S, Comino A, Fruttero A, Torchio P, Bouzari H, Taraglio S, et al. Flow cytometric DNA analysis of cirrhotic liver cells in patients with hepatocellular carcinoma can provide a new prognostic factor. Cancer 1996; 78: 1195202.
  • 26
    Arakawa M, Kage M, Sugihara S, Nakashima T, Suenaga M, Okuda K. Emergence of malignant lesions within an adenomatous nodule in cirrhotic liver: observation in five cases. Gastroenterology 1988; 95: 16646.
  • 27
    Sakamoto M, Hirohashi S, Shimosato Y. Early stages of multistep hepatocarcinogenesis adenomatous hyperplasia and early hepatocellular carcinoma. Hum Pathol 1991; 22: 1728.
  • 28
    Chen PJ, Chen DS, Lai MY, Chang MH, Huang GT, Yang PM, et al. Clonal origin of recurrent hepatocellular carcinoma. Gastroenterology 1989; 96: 5279.
  • 29
    Yamamoto T, Kajino K, Kudo M, Sasaki Y, Arakawa Y, Hino O. Determination of the clonal origin of multiple human hepatocellular carcinomas by cloning and polymerase chain reaction of the integrated hepatitis B virus DNA. Hepatology 1999; 29: 144652.
  • 30
    Majno PE, Adam R, Bismuth H, Castaing D, Ariche A, Krissat J, et al. Influence of preoperative transarterial chemoembolization on resection and transplantation for hepatocellular carcinoma in patients with cirrhosis. Ann Surg 1997; 226: 688703.
  • 31
    Nonami T, Isshiki K, Katoh H, Kishimoto W, Harada A, Nakao A, et al. The potential role of postoperative hepatic artery chemotherapy in patients with high-risk hepatomas. Ann Surg 1991; 213: 2226.
  • 32
    Tanaka K, Shimada H, Togo S, Takahashi T, Endo I, Sekido H, et al. Use of transcatheter arterial infusion of anticancer agents with lipiodol to prevent recurrence of hepatocellular carcinoma after hepatic resection. Hepatogastroenterology 1999; 46: 10838.
  • 33
    Muto Y, Moriwaki H, Ninomiya M, Adachi S, Saito A, Takasaki KT, et al. Prevention of second primary tumors by an acyclic retinoid, polyprenoic acid, in patients with hepatocellular carcinoma. N Engl J Med 1996; 334: 15617.